Clinical trial
Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal…
NCT00428285 · Centre hospitalier de l'Université de Montréal (CHUM), Other · Completed
Key facts
| NCT number | NCT00428285 |
|---|---|
| Title | Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men |
| Official title | A Phase II, Prospective, Open-label, Pilot Study of the Tolerability, Safety, and Efficacy of Argon Plasma Coagulation for the Treatment of Anal Intraepithelial Neoplasia Grade 2 or 3 in HIV-positive Men Having Sex With Men |
| Lead sponsor | Centre hospitalier de l'Université de Montréal (CHUM), Other |
| Collaborators | McGill University Health Centre/Research Institute of the McGill University Health Centre CIHR Canadian HIV Trials Network |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anus Neoplasms, HIV Infections |
| Intervention type | Procedure |
| Interventions | Argon Plasma Coagulation |
| Enrollment | 20 |
| Start date | Feb 1, 2007 |
| Primary completion | Feb 1, 2010 |
| Completion | Jul 1, 2016 |
| First posted | Jan 29, 2007 |
| Last update posted | May 1, 2019 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: